πŸ‡ΊπŸ‡Έ FDA
Patent

US 7745608

Modified iRNA agents

granted A61KA61K47/55A61K47/554

Quick answer

US patent 7745608 (Modified iRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K47/55, A61K47/554, A61P, A61P31/14